Mark Y Chan Selected Research

Dyslipidemias (Dyslipidemia)

1/2022

Plasma Ceramides in Cardiovascular Disease Risk Stratification.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Y Chan Research Topics

Disease

28	Myocardial Infarction 06/2022 - 01/2007
25	ST Elevation Myocardial Infarction 06/2022 - 04/2007
17	Thrombosis (Thrombus) 04/2022 - 04/2007
13	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 06/2008
11	Hemorrhage 09/2022 - 08/2010
11	Acute Coronary Syndrome 01/2021 - 12/2010
9	Heart Failure 09/2022 - 01/2015
9	Stroke (Strokes) 04/2022 - 06/2010
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2005
5	Infarction (Infarctions) 06/2022 - 05/2014
4	Reperfusion Injury 10/2020 - 05/2014
3	Atrial Fibrillation 09/2022 - 12/2012
3	Ventricular Remodeling 01/2021 - 07/2019
3	Inflammation (Inflammations) 01/2021 - 12/2012
3	Pathologic Constriction (Stenosis) 06/2015 - 08/2008
2	Cicatrix (Scar) 06/2022 - 10/2019
2	Death (Near-Death Experience) 04/2022 - 04/2018
2	Ischemic Stroke 01/2022 - 10/2021
2	Thrombocytopenia (Thrombopenia) 01/2022 - 02/2008
2	Neoplasms (Cancer) 10/2021 - 01/2021
2	Coronary Disease (Coronary Heart Disease) 10/2020 - 11/2008
2	Diabetes Mellitus 11/2018 - 01/2015
1	Cognitive Dysfunction 09/2022
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	COVID-19 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Out-of-Hospital Cardiac Arrest 11/2021
1	Infections 01/2021
1	Pancreatic Diseases (Pancreatic Disease) 12/2020
1	Ventricular Dysfunction 12/2020
1	Heart Arrest (Cardiac Arrest) 11/2019

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2015
11	Clopidogrel (Plavix)FDA Link 06/2022 - 06/2008
6	AnticoagulantsIBA 09/2022 - 02/2008
6	TicagrelorIBA 06/2022 - 05/2016
5	Pharmaceutical PreparationsIBA 01/2022 - 02/2008
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2021 - 06/2008
4	omega-Chloroacetophenone (Mace)IBA 01/2022 - 07/2013
4	PolymersIBA 01/2022 - 04/2007
3	MicroRNAs (MicroRNA)IBA 10/2020 - 01/2017
3	Everolimus FDA Link 07/2016 - 08/2013
3	Prasugrel Hydrochloride FDA Link 05/2016 - 11/2012
2	Warfarin (Coumadin)FDA LinkGeneric 09/2022 - 12/2012
2	LipidsIBA 01/2022 - 10/2021
2	CeramidesIBA 01/2022 - 04/2018
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2022
2	bivalirudin (Angiomax)FDA Link 11/2021 - 01/2017
2	CholesterolIBA 10/2021 - 01/2012
2	HDL CholesterolIBA 10/2021 - 01/2012
2	Thromboplastin (Tissue Factor)IBA 01/2021 - 10/2009
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2012
2	Blood Proteins (Serum Proteins)IBA 10/2020 - 12/2012
2	Purinergic P2Y Receptor AntagonistsIBA 08/2020 - 01/2018
2	CreatinineIBA 11/2019 - 11/2008
2	pro-brain natriuretic peptide (1-76)IBA 10/2019 - 07/2017
2	Sirolimus (Rapamycin)FDA Link 01/2019 - 04/2007
2	erucylphosphocholineIBA 01/2019 - 07/2011
2	Phenobarbital (Luminal)FDA Link 06/2015 - 07/2011
2	MetalsIBA 01/2015 - 06/2010
2	Factor IXa (Coagulation Factor IXa)IBA 12/2009 - 06/2008
1	Vitamin K FDA Link 09/2022
1	GadoliniumIBA 06/2022
1	Thrombin FDA Link 06/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 04/2022
1	Polysaccharides (Glycans)IBA 01/2022
1	Uric Acid (Urate)IBA 01/2022
1	VaccinesIBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	SodiumIBA 01/2022
1	LDL CholesterolIBA 10/2021
1	Triglycerides (Triacylglycerol)IBA 10/2021
1	oxidized low density lipoproteinIBA 10/2021
1	Omeprazole (Prilosec)FDA LinkGeneric 10/2021
1	CalciumIBA 10/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021
1	EnzymesIBA 12/2020
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 10/2020
1	Dihydrotachysterol (AT 10)IBA 10/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020
1	Angiotensin Receptor AntagonistsIBA 01/2020
1	LDL Lipoproteins (beta Lipoproteins)IBA 12/2019
1	TroponinIBA 11/2019
1	Hemoglobins (Hemoglobin)IBA 11/2019
1	CollagenIBA 10/2019
1	Tissue Inhibitor of Metalloproteinase-1IBA 10/2019

Therapy/Procedure

28	Percutaneous Coronary Intervention 06/2022 - 04/2007
15	Stents 04/2022 - 04/2007
15	Therapeutics 11/2021 - 02/2008
9	Drug-Eluting Stents 01/2022 - 01/2007
5	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 08/2008
2	Patient Readmission 01/2019 - 01/2018
2	Secondary Prevention 01/2016 - 02/2008
1	Length of Stay 09/2022
1	Resuscitation 11/2021